Lenalidomide
A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.
Year introduced: 2019 (2002)
PubMed search builder options
Subheadings:
Tree Number(s): D02.241.223.805.810.400, D03.383.621.808.519, D03.633.100.513.750.563
MeSH Unique ID: D000077269
Registry Number: F0P408N6V4
Entry Terms:
- IMiD3 Cpd
- 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
- 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-
- CC 5013
- CC-5013
- CC5013
- Revlimid
- Revimid
Pharmacologic Action: